Nephros, Inc. (NASDAQ: NEPH), a commercial-stage company providing water purification services to commercial and medical markets, recently provided preliminary financial results for 2021 as well as an outlook on 2022 financials in its press release.
2021 Financial Result Predictions
Expected revenue of $10.4 million, which is the highest for the company so far, and a 21% increase from last year
Expected Q4 revenue of $2.8 million, an 18% increase from Q4 2020
Official financial results will be announced Wednesday, February 2022.
2022 Financial Guidance
Andor Astor, President and CEO of Nephros, offered revenue guidance on behalf of the company, anticipating a 2022 revenue of $13 to $13.5 million.
Astor had also stated in the Q3 press release of the company’s financial results that “our Pathogen Detection Systems (PDS) business segment generated small but promising new revenue. We believe this relatively young business will see significant growth in 2022.”
You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Content on the Site is provided for information purposes only, and none of the information contained on the Site constitutes an offer, solicitation or recommendation to buy or sell a security.